197
Participants
Start Date
October 27, 2008
Primary Completion Date
February 6, 2009
Study Completion Date
March 31, 2025
AZD2281
Oral single dose formulation
Research Site, Randwick
Research Site, Leuven
Research Site, Bellinzona
Research Site, Edinburgh
Research Site, London
Research Site, Manchester
Research Site, Newcastle upon Tyne
Research Site, Northwood
Research Site, Oxford
Research Site, Sutton
Lead Sponsor
AstraZeneca
INDUSTRY